L851-2630 Screening compound: 1-{3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-1-methyl-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}-3-piperidino-1-propanone

L851-2630 Screening compound: 1-{3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-1-methyl-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}-3-piperidino-1-propanone
L851-2630 Screening compound: 1-{3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-1-methyl-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}-3-piperidino-1-propanone alternative view

Chemical Structure Depiction of ChemDiv screening compound L851-2630
1-{3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-1-methyl-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}-3-piperidino-1-propanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L851-2630

Molecular Formula

C23H27FN6O2 (C23 H27 FN6 O2)

Compound Name

1-{3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-1-methyl-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}-3-piperidino-1-propanone

IUPAC name

1-{3-[3-(4-fluorophenyl)-124-oxadiazol-5-yl]-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl}-3-(piperidin-1-yl)propan-1-one

SMILES

Cn(c(CC1)c2CN1C(CCN1CCCCC1)=O)nc2-c1nc(-c(cc2)ccc2F)no1

InChI

InChI=1S/C23H27FN6O2/c1-28-19-9-14-30(20(31)10-13-29-11-3-2-4-12-29)15-18(19)21(26-28)23-25-22(27-32-23)16-5-7-17(24)8-6-16/h5-8H,2-4,9-15H2,1H3

InChI Key

BPIVIIFZIASIBX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27480413

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

438.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.500

Distribution Coefficient, logD

0.575

Water Solubility, LogSw

-2.50

Polar Surface Area

66.427

Acid Dissociation Constant (pKa)

22.82

Base Dissociation Constant (pKb)

9.32

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

47.83

L851-2630 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L851-2630 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L851-2630?
Check Price and Availability of L851-2630, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L851-2630 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L851-2630
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L851-2630
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L851-2630 available by request